Table 1.
Baseline patient characteristics. Data are n, with percentages in parentheses, or mean ± SD, unless otherwise indicated
| Characteristic | All patients (n = 18) |
|---|---|
| Age, years | 69.2 ± 8.7 |
| Male | 10 (56 %) |
| Culprit region | |
| LAD | 9 (50 %) |
| LCx | 2 (11 %) |
| RCA | 7 (39 %) |
| Time from onset to revascularization, h | 5.4 ± 6.8 |
| Revascularization method, n (%) | |
| Stent | 18 (100 %) |
| Peak creatine kinase, IU/L | 1697.6 ± 1522.5 |
| Coronary risk factor, n (%) | |
| Hypertension | 9 (50 %) |
| Diabetes mellitus | 5 (28 %) |
| Dyslipidemia | 10 (56 %) |
| Smoking history | 9 (50 %) |
| Past history | |
| Pacemaker implantation | 1 (6 %) |
| Post PCI | 1 (6 %) |
| Hemodynamics | |
| Systolic blood pressure, mmHg | 122.7 ± 14.9 |
| Diastolic blood pressure, mmHg | 62.3 ± 9.9 |
| Heart rate, beats per min | 63.3 ± 9.2 |
| Echocardiography data | |
| LVEF, % | 56.5 ± 9.5 |
| Interventricular septal wall thickness, mm (range) | 10.4 ± 1.9 (7–16) |
| Posterior wall thickness, mm (range) | 9.2 ± 1.1 (7–12) |
LAD left anterior descending artery, LCx left circumflex artery, RCA right coronary artery, PCI percutaneous coronary intervention, LVEF left ventricular ejection fraction